Patents by Inventor Wendy Maury

Wendy Maury has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AXL Inhibitors for Antiviral Therapy
    Publication number: 20230250169
    Abstract: This disclosure relates to compostions and methods for preventing and treating a viral infection in a subject. In particular, the present disclosure provides compostions and methods of preventing or treating infection of a subject with a coronavirus such as the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) that causes the disease COVID-19.
    Type: Application
    Filed: April 1, 2021
    Publication date: August 10, 2023
    Applicant: BERGENBIO ASA
    Inventors: James Bradley LORENS, Wendy MAURY
  • Tannin inhibitors of HIV
    Patent number: 9370529
    Abstract: The invention provides a method to prevent or treat HIV-infection with synthetic tannins, and pharmaceutical compositions comprising synthetic tannins.
    Type: Grant
    Filed: August 18, 2015
    Date of Patent: June 21, 2016
    Assignees: University of Iowa Research Foundation, Iowa State University Research Foundation, Inc.
    Inventors: George A. Kraus, Wendy Maury
  • TANNIN INHIBITORS OF HIV
    Publication number: 20160038520
    Abstract: The invention provides a method to prevent or treat HIV-infection with synthetic tannins, and pharmaceutical compositions comprising synthetic tannins.
    Type: Application
    Filed: August 18, 2015
    Publication date: February 11, 2016
    Inventors: George A. Kraus, Wendy Maury
  • Tannin inhibitors of HIV
    Patent number: 9181291
    Abstract: The invention provides a method to prevent or treat HIV-infection with synthetic tannins, and pharmaceutical compositions comprising synthetic tannins.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: November 10, 2015
    Assignees: University of Iowa Research Foundation, Iowa State University Research Foundation, Inc.
    Inventors: George A. Kraus, Wendy Maury
  • TANNIN INHIBITORS OF HIV
    Publication number: 20130252909
    Abstract: The invention provides a method to prevent or treat HIV-infection with synthetic tannins, and pharmaceutical compositions comprising synthetic tannins.
    Type: Application
    Filed: March 7, 2013
    Publication date: September 26, 2013
    Applicant: University of Iowa Research Foundation
    Inventors: George A. Kraus, Wendy Maury
  • Vectors with viral insulators
    Publication number: 20060233757
    Abstract: The invention provides a vector with an isolated viral insulator or variants thereof and uses therefor, e.g., gene therapy or transgenics.
    Type: Application
    Filed: August 29, 2005
    Publication date: October 19, 2006
    Inventor: Wendy Maury
  • Novel antiviral acitivities of primate theta defensins and mammalian cathelicidins
    Publication number: 20040086535
    Abstract: The present invention relates to the use of anti-viral peptides in the inhibition and treatment of viral infections, in particular infections caused by enveloped viruses. These anti-viral peptides, some natural and others artificial, adopt either amphiphilic alpha-helical or a theta structure where the homodimeric or heterodirner peptides are joined by both cysteine bonds and circularization of the peptides. These agents may be used alone or in combination with more traditional anti-viral pharmaceuticals.
    Type: Application
    Filed: November 25, 2003
    Publication date: May 6, 2004
    Applicant: The University of Iowa Research Foundation
    Inventors: Wendy Maury, Jack Stapleton, Richard Roller, Mark Stinski, Paul B. McCray, Brian Tack
  • Novel antiviral activities primate theta defensins and mammalian cathelicidins
    Publication number: 20030022829
    Abstract: The present invention relates to the use of anti-viral peptides in the inhibition and treatment of viral infections, in particular infections caused by enveloped viruses. These anti-viral peptides, some natural and others artificial, adopt either amphiphilic alpha-helical or a theta structure where the homodimeric or heterodimer peptides are joined by both cysteine bonds and circularization of the peptides. These agents may be used alone or in combination with more traditional anti-viral pharmaceuticals.
    Type: Application
    Filed: January 29, 2002
    Publication date: January 30, 2003
    Inventors: Wendy Maury, Jack Stapleton, Richard Roller, Mark Stinski, Paul B. McCray, Brian Tack